Karlsson MO - Search Results

1

The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.

Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO. Gisleskog PO, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1999 Jan;47(1):53-8. doi: 10.1046/j.1365-2125.1999.00843.x. Br J Clin Pharmacol. 1999. PMID: 10073740 Free PMC article. Clinical Trial.

2

Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.

Rydberg T, Jönsson A, Karlsson MO, Melander A. Rydberg T, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1997 Apr;43(4):373-81. doi: 10.1046/j.1365-2125.1997.00571.x. Br J Clin Pharmacol. 1997. PMID: 9146849 Free PMC article. Clinical Trial.

3

Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria.

Sidhu JS, Ashton M, Huong NV, Hai TN, Karlsson MO, Sy ND, Jonsson EN, Cong LD. Sidhu JS, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1998 Apr;45(4):347-54. doi: 10.1046/j.1365-2125.1998.t01-1-00686.x. Br J Clin Pharmacol. 1998. PMID: 9578181 Free PMC article.

4

Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.

Gardmark M, Karlsson MO, Jonsson F, Hammarlund-Udenaes M. Gardmark M, et al. Among authors: karlsson mo. J Pharm Sci. 1998 Jul;87(7):813-20. doi: 10.1021/js980056f. J Pharm Sci. 1998. PMID: 9649348

5

A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.

Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO. Gisleskog PO, et al. Among authors: karlsson mo. Clin Pharmacol Ther. 1998 Dec;64(6):636-47. doi: 10.1016/S0009-9236(98)90054-6. Clin Pharmacol Ther. 1998. PMID: 9871428 Clinical Trial.

6

Interchangeability and predictive performance of empirical tolerance models.

Gårdmark M, Brynne L, Hammarlund-Udenaes M, Karlsson MO. Gårdmark M, et al. Among authors: karlsson mo. Clin Pharmacokinet. 1999 Feb;36(2):145-67. doi: 10.2165/00003088-199936020-00005. Clin Pharmacokinet. 1999. PMID: 10092960 Review.

7

Validation of a population pharmacokinetic/pharmacodynamic model for 5 alpha-reductase inhibitors.

Olsson Gisleskog P, Hermann D, Hammarlund-Udenaes M, Karlsson MO. Olsson Gisleskog P, et al. Among authors: karlsson mo. Eur J Pharm Sci. 1999 Aug;8(4):291-9. doi: 10.1016/s0928-0987(99)00024-x. Eur J Pharm Sci. 1999. PMID: 10425379 Clinical Trial.

8

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Hassan M, Svensson US, Ljungman P, Björkstrand B, Olsson H, Bielenstein M, Abdel-Rehim M, Nilsson C, Johansson M, Karlsson MO. Hassan M, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1999 Nov;48(5):669-77. doi: 10.1046/j.1365-2125.1999.00090.x. Br J Clin Pharmacol. 1999. PMID: 10594468 Free PMC article. Clinical Trial.

9

A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction.

Milligan PA, Marshall SF, Karlsson MO. Milligan PA, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 2002;53 Suppl 1(Suppl 1):45S-52S. doi: 10.1046/j.0306-5251.2001.00032.x. Br J Clin Pharmacol. 2002. PMID: 11879259 Free PMC article. Clinical Trial.

10

Use of prior information to stabilize a population data analysis.

Gisleskog PO, Karlsson MO, Beal SL. Gisleskog PO, et al. Among authors: karlsson mo. J Pharmacokinet Pharmacodyn. 2002 Dec;29(5-6):473-505. doi: 10.1023/a:1022972420004. J Pharmacokinet Pharmacodyn. 2002. PMID: 12795242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters